Back

Ampk activation by glycogen expenditure primes the exit of naive pluripotency

Kim, S.-M.; Kwon, E.-J.; Oh, J.-Y.; Kim, H. S.; Park, S.; Jang, G.; Do, J. T.; Kim, K.-T.; Cha, H.-J.

2023-05-22 developmental biology
10.1101/2023.05.19.541467 bioRxiv
Show abstract

Embryonic and epiblast stem cells in pre-and post-implantation embryos are characterized by their naive and primed states, respectively, which represent distinct phases of pluripotency. Thus, the cellular transition from naive to primed pluripotency recapitulates a drastic metabolic and cellular remodeling after implantation to adapt to changes in extracellular conditions. Here, we found that inhibition of Ampk occurred during naive transition with two conventional inhibitors (2i) of the Mek1 and Gsk3{beta} pathways. The accumulation of glycogen due to the inhibition of Gsk3{beta} was responsible for Ampk inhibition, which accounted for high de novo fatty acid synthesis in naive embryonic stem cells (ESCs). The knockout of glycogen synthase 1 (Gys1) in naive ESCs (GKO), resulting in a drastic glycogen loss, led to a robust Ampk activation and lowered the level of fatty acids. GKO lost the cellular characteristics of naive ESCs and rapidly transitioned to a primed state, as evidenced by a decrease in pluripotency markers in teratoma from GKO. The characteristics of GKO were restored by the simultaneous knockout of Ampk. These findings suggest that glycogen in naive ESCs within the blastocyst may act as a signaling molecule for the timely activation of Ampk, thus ultimately contributing to the transition to the epiblast stage. Graphical Summary O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=108 SRC="FIGDIR/small/541467v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@118ea81org.highwire.dtl.DTLVardef@cbe4bforg.highwire.dtl.DTLVardef@16d5c1org.highwire.dtl.DTLVardef@12b825c_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Stem Cell Reports
118 papers in training set
Top 0.1%
25.4%
2
eLife
5422 papers in training set
Top 9%
8.3%
3
Stem Cells
28 papers in training set
Top 0.1%
7.1%
4
iScience
1063 papers in training set
Top 1.0%
6.8%
5
Cell Reports
1338 papers in training set
Top 8%
6.3%
50% of probability mass above
6
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 0.7%
6.3%
7
Development
440 papers in training set
Top 0.8%
3.6%
8
Nature Communications
4913 papers in training set
Top 42%
3.2%
9
PLOS Biology
408 papers in training set
Top 7%
2.1%
10
EMBO reports
136 papers in training set
Top 2%
1.8%
11
The EMBO Journal
267 papers in training set
Top 2%
1.7%
12
Cell Death Discovery
51 papers in training set
Top 0.6%
1.7%
13
Developmental Cell
168 papers in training set
Top 8%
1.7%
14
Cell Stem Cell
57 papers in training set
Top 1%
1.3%
15
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.3%
1.3%
16
Cell Discovery
54 papers in training set
Top 4%
0.9%
17
Cell Death & Differentiation
48 papers in training set
Top 0.5%
0.9%
18
Cells
232 papers in training set
Top 6%
0.8%
19
Science China Life Sciences
26 papers in training set
Top 2%
0.8%
20
Advanced Science
249 papers in training set
Top 19%
0.7%
21
BMC Biology
248 papers in training set
Top 4%
0.7%
22
Biology Open
130 papers in training set
Top 3%
0.7%
23
Communications Biology
886 papers in training set
Top 27%
0.7%
24
Life Science Alliance
263 papers in training set
Top 2%
0.6%
25
International Journal of Molecular Sciences
453 papers in training set
Top 18%
0.6%
26
Aging Cell
144 papers in training set
Top 4%
0.6%
27
EMBO Reports
88 papers in training set
Top 1%
0.6%